Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years.

por Winters, M A, Shafer, R W, Jellinger, R A, Mamtora, G, Gingeras, T, Merigan, T C
Publicado em 1997